These observations uncover a novel molecular mechanism by which the Hh-Gli1-FoxM1 axis mediates CRC cell proliferation and provide a potential valid therapeutic target for the treatment of CRC in the future. This evidence concerns the gene GLI1 and colorectal carcinoma.